Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
Research.Patient.info

Solid malignant tumors research hub

2 indexed studies · 2 currently recruiting

  • recruitingTherapeutic exploratory (Phase II)

    (22551) A single arm, open-label, multicenter Phase 2 study of regorafenib in participants who have been treated in a previous Bayer-sponsored regorafenib study (monotherapy or combination treatment) that has reached the primary completion endpoint, or main data analysis, or has been stopped prematurely.

    This study is for adults with solid cancer tumours who previously took part in an earlier trial using regorafenib. It allows people to continue receiving this targeted cancer medication safely while doctors closely monitor any side effects and see if doses need to be changed over time.

    Spain · France
  • recruitingTherapeutic confirmatory (Phase III)

    A Single-Arm Open-Label Multi-Centre Extension Study of Pertuzumab Administered as a Single Agent or in Combination with other Anti-Cancer Therapies in Patients Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Study

    This study is for adults with solid cancer tumours who previously took part in an earlier trial of a medicine called pertuzumab. It allows them to keep receiving pertuzumab, either alone or with other cancer drugs, while doctors carefully check for any side effects and see how their cancer responds.

    Portugal · Italy · Spain
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.